About QED Therapeutics & BridgeBio Pharma

QED Therapeutics, an affiliate of BridgeBio Pharma, focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-driven short stature, which causes potentially debilitating medical complications. With our experimental therapeutic candidate, infigratinib, we seek to provide an option to children living with Achondroplasia and their families.
 
Our business is inspired by our values:

• PUT PATIENTS FIRST
• LET SCIENCE SPEAK
• EVERY MINUTE COUNTS
• THINK INDEPENDENTLY
• BE RADICALLY TRANSPARENT

FGFR=fibroblast growth factor receptor.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, Raleigh, and with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zug, Switzerland, and are expanding across Europe.

To learn more about our story and company culture, visit us at https://www.qedtx.com/ | https://bridgebio.com 

Who You Are

The Business Development & Operations (BD & Ops) is a high-visibility strategic role that is focused on risk-trade off assessments in drug development decisions, with an ability to execute on business development transactions when necessary. This includes setting up strategic timelines, the scientific plan, business plan, strategy, NPV modeling, Gantt Charts, vendor relations, contract negotiations, execution and management. The Associate Director of BD&Ops reports to the Senior Director of Strategy and Operations at BridgeBio, and will specifically focus on the strategic, competitive intelligence and business development activities for the QED Therapeutics, the skeletal dysplasias affiliate within BridgeBio. The candidate must have demonstrated excellence at managing diverse stakeholders, many at a very senior level, and exquisite attention to detail. Given the intense focus on science within BridgeBio, the candidate must have a solid scientific background and knowledge of drug development process. 

Responsibilities

• Driving cross-functional alignment and harmonization of strategy with operational activities for the expansion area clinical program
• Identifying and collaborating with functional experts as strategic partners to support the success of infigratinib
• Owning competitive intelligence for achondroplasia and hypochondroplasia
• Able to run a partnering process under some supervision (e.g. introductory calls with third parties, initial negotiations – verbal, in-person, emails)
• Supporting the development of infigratinib and evaluating strategic investment 
• Performing other strategic analyses as needed by the Company
• Set, prioritize and manage milestones & deliverables for team members in one or more subsidiary companies
• Coordinate team meetings and delegate to technical experts in one or more subsidiary companies
• Interpret, collate, and communicate critical data findings in a concise manner to senior management
• Ability & desire to identify problems, locate the resources and find data-driven solutions independent of supervision

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in themselves and those around them
• High-quality executors, who execute against goals and milestones with quality, precision, and speed

Education, Experience & Skills Requirements

• This role is hybrid, with a preference for Bay Area-based candidates
• 2 to 6 years of relevant strategic planning/business development experience in biopharma
• Ph.D., MD, or other graduate degrees in the life sciences strongly preferred
• Management Consulting or Banking experience from top tier firm
• Proven scientific acumen, communication skills, and an analytical mindset
• Ability to handle multiple projects simultaneously
• Comfort working independently and as part of a diverse team
• Exceptional written communication and presentation skills
• Demonstrated ability to solve problems using a structured, analytical approach
• Familiarity with the drug discovery & development process
• Comfort with ambiguity and a self-starter attitude
• Exquisitely detail-oriented

Candidate Attributes

• You are patient-driven - Everything we do impacts the life of a patient
• You have a detailed curiosity for science 
• You have demonstrated the ability to thrive in an intense environment - whatever your background, you are pressure tested.
• Successfully manage, prioritize, and deliver multiple competing priorities
• Attention to detail and strong organizational skills 
• You are a master ’improviser" - so much of the drug development world is unpredictable, you must be comfortable with a significant degree of ambiguity
• You have the confidence to chart your course - you can identify problems, locate the resources and find data-driven solutions independent of supervision
• Unrivaled sense of urgency - like our unique drug development processes, our employees need to optimize for speed

What We Offer

• Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• An unyielding commitment to always putting patients first. Learn more about how we do this here
• A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• A place where you own the vision – both for your program and your own career path
• A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• Access to learning and development resources to help you get in the best professional shape of your life
• Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• Flexible PTO
• Rapid career advancement for strong performers
• Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time 
• Partnerships with leading institutions
• Commitment to Diversity, Equity & Inclusion